The L-arginine/nitric oxide pathway and non-adrenergic, non-cholinergic relaxation of the lower urinary tract
Related Experiment Videos
1Department of Clinical Pharmacology, University of Lund, Sweden.
General Pharmacology
|July 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Release of atrial natriuretic peptide during pulmonary artery clamping in man.
Clinical physiology (Oxford, England)·1997
NANC transmitters in the female pig urethra--localization and modulation of release via alpha 2-adrenoceptors and potassium channels.
British journal of pharmacology·1997
Neurotransmitter release evoked by alpha-latrotoxin in the smooth muscle of the female pig urethra.
Naunyn-Schmiedeberg's archives of pharmacology·1997
Morphological relations between haem oxygenases, NO-synthase and VIP in the canine and feline gastrointestinal tracts.
Journal of the autonomic nervous system·1997
Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin.
General pharmacology·2002
Investigation of basal endothelial function in the obese Zucker rat in vitro.
General pharmacology·2002
Cerebrospinal fluid p62/SQSTM1 is associated with tau pathology, brain structural alterations, and cognitive impairment in adults without dementia.
Journal of Alzheimer's disease : JAD·2026
Deciphering the neuroprotective signaling of SGLT2 inhibitors in Alzheimer's disease.
Journal of Alzheimer's disease : JAD·2026
The Association of Amyloid-β and Tau With Synaptic Dysfunction in Alzheimer's Disease.
Annals of clinical and translational neurology·2026